In reports on ESCC, miR-29c-3p targets the CCNA2-mediated p53 signaling pathway, represses malignant phenotypes of ESCC cells and arrests cells in G0/G1 phase9. Here, TP53 is linked to esophageal squamous cell carcinoma.